Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review on Treatment Disparity

Coronary artery disease (CAD) is a significant contributor to mortality in America. A common risk factor of CAD is hyperlipidemia. Treatment guidelines of hyperlipidemia are well established. Statins are the cornerstone of treating hyperlipidemia. New medications such as proprotein convertase subtil...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cureus
Main Authors: Singh, Chetana, Valero, Danel J, Nisar, Javariya, Trujillo Ramirez, Jose I, Kothari, Karisma K, Isola, Sasank, San Hernandez, Aleyda M, Gordon, Domonick K
Formato: Artigo
Idioma:Inglês
Publicado em: Cureus 2020
Assuntos:
Cardiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7667606/
https://ncbi.nlm.nih.gov/pubmed/33209524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.10965
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados